Conformably, Jing et al. have demonstrated that NCAPD3 induces the expression of glycolytic regulators (GLUT1, HK2, ENO1, PKM2 and LDHA), and finally promotes the progression of CRC [41]. Here, SLC2A1 is linked to colorectal carcinoma.